Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 10;10(103):eadq1697.
doi: 10.1126/sciimmunol.adq1697. Epub 2025 Jan 10.

Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

Marita Bosticardo  1 Kerry Dobbs  1 Ottavia M Delmonte  1 Andrew J Martins  2 Francesca Pala  1 Tomoki Kawai  1 Heather Kenney  1 Gloria Magro  1 Lindsey B Rosen  1 Yasuhiro Yamazaki  1 Hsin-Hui Yu  1   3 Enrica Calzoni  1 Yu Nee Lee  4 Can Liu  2 Jennifer Stoddard  5 Julie Niemela  5 Danielle Fink  6 Riccardo Castagnoli  1 Meredith Ramba  7 Aristine Cheng  1 Deanna Riley  8 Vasileios Oikonomou  1 Elana Shaw  1 Brahim Belaid  9 Sevgi Keles  10 Waleed Al-Herz  11   12 Caterina Cancrini  13   14 Cristina Cifaldi  13 Safa Baris  15   16 Svetlana Sharapova  17 Catharina Schuetz  18 Andrew R Gennery  19 Alexandra F Freeman  1 Raz Somech  4 Sharon Choo  20 Silvia C Giliani  21   22   23 Tayfun Güngör  24   25 Daniel Drozdov  24   25   26 Isabelle Meyts  27   28 Despina Moshous  29   30 Benedicte Neven  29   30 Roshini S Abraham  31 Aisha El-Marsafy  32 Maria Kanariou  33 Alejandra King  34 Francesco Licciardi  35 Mario E Cruz-Muñoz  36 Paolo Palma  13   37 Cecilia Poli  38 Mehdi Adeli  39 Mattia Algeri  40   41 Fayhan J Alroqi  42 Paul Bastard  43   44 Jenna R E Bergerson  1 Claire Booth  45 Ana Brett  46   47 Siobhan O Burns  48   49 Manish J Butte  50 Nurcicek Padem  51 M de la Morena  52 Ghassan Dbaibo  53   54 Suk See de Ravin  1 Dimana Dimitrova  55 Reda Djidjik  9 Mayra B Dorna  56 Cullen M Dutmer  57 Reem Elfeky  58 Fabio Facchetti  59 Ramsay L Fuleihan  60 Raif S Geha  61 Luis I Gonzalez-Granado  62   63   64 Liis Haljasmägi  65 Hanadys Ale  66   67 Anthony Hayward  68 Anna M Hifanova  69 Winnie Ip  45 Blanka Kaplan  70   71 Neena Kapoor  72 Elif Karakoc-Aydiner  15   16 Jaanika Kärner  65 Michael D Keller  73 Blachy J Dávila Saldaña  73 Ayça Kiykim  74 Taco W Kuijpers  75 Elena E Kuznetsova  76 Elena A Latysheva  77 Jennifer W Leiding  78   79   80 Franco Locatelli  40   41 Guisela Alva-Lozada  81 Christine McCusker  82 Fatih Celmeli  83 Megan Morsheimer  84 Ahmet Ozen  15   16 Nima Parvaneh  85 Srdjan Pasic  86 Alessandro Plebani  87 Kahn Preece  88 Susan Prockop  89 Inga S Sakovich  17 Elena E Starkova  90 Troy Torgerson  91 James Verbsky  92 Jolan E Walter  93 Brant Ward  94 Elizabeth L Wisner  95 Deborah Draper  1 Katherine Myint-Hpu  1 Pooi M Truong  1 Michail S Lionakis  1 Morgan B Similuk  96 Centralized Sequencing Program Group§§Magdalena A Walkiewicz  96 Amy Klion  97 Steven M Holland  1 Cihan Oguz  98 Dusan Bogunovic  99 Kai Kisand  65 Helen C Su  1   100 John S Tsang  2 Douglas Kuhns  6 Anna Villa  101   102 Sergio D Rosenzweig  5 Stefania Pittaluga  8 Luigi D Notarangelo  1 Centralized Sequencing Program Group
Collaborators, Affiliations

Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

Marita Bosticardo et al. Sci Immunol. .

Abstract

Human recombination-activating gene (RAG) deficiency can manifest with distinct clinical and immunological phenotypes. By applying a multiomics approach to a large group of RAG-mutated patients, we aimed at characterizing the immunopathology associated with each phenotype. Although defective T and B cell development is common to all phenotypes, patients with hypomorphic RAG variants can generate T and B cells with signatures of immune dysregulation and produce autoantibodies to a broad range of self-antigens, including type I interferons. T helper 2 (TH2) cell skewing and a prominent inflammatory signature characterize Omenn syndrome, whereas more hypomorphic forms of RAG deficiency are associated with a type 1 immune profile both in blood and tissues. We used cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) analysis to define the cell lineage-specific contribution to the immunopathology of the distinct RAG phenotypes. These insights may help improve the diagnosis and clinical management of the various forms of the disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: M.J.B. is a speaker for Grifols; consults for Pharming, Horizon/Amgen, and Grifols; receives sponsored research funding from the NIH, the Bill and Melinda Gates Foundation, and Pharming; and serves on the scientific advisory board for ADMA Biologics. H.C.S. has stock holdings in Amgen and Eli Lily. R.S.A. receives royalties from Elsevier for book publications, serves as deputy editor for the Journal of Immunology, is Committee Chair of Newborn Screening for SCID for the Clinical and Laboratory Standards Institute, and is a member of the Immunology Clinical Domain Working Group for ClinGen. B.J.D.S. is an ad hoc consultant for Sobi and a member of the Data Safety Monitoring Board for Orchard Therapeutics. I.M. is a senior Clinical Researcher at the FWO Flanders. R.L.F. has consulted for Takeda, Griffons, Horizon, and Pharming. B.W. serves as consultant for the Immunology Speakers Bureau, Takeda Pharmaceutocals. S. Prockop receives support for the conduct of clinical trials through Boston Children’s Hospital from AlloVir, Atara, and Jasper. She is an inventor of intellectual property related to development of third-party virus-specific T cells program with all rights assigned to Memorial Sloan Kettering Cancer Center; receives honoraria from Pierre Fabre, Regeneron; serves on the data safety monitoring board at Stanford University and New York Blood Center; and is consulting for Atara, Ensoma, Pierre Fabre, HEOR and VOR. J.S.T. serves on the scientific advisory board of CytoReason Inc. and Immunoscape Inc. and as the co–chief science officer (unpaid) of the Human Immunome Project (nonprofit). All other authors declare that they have no competing interests.

Similar articles

Cited by

  • Probing the diagnosis of SCID through in vitro T-cell development: Experience in 2 centers in North America.
    Soulard C, Pala F, Bosticardo M, Haddad E. Soulard C, et al. J Allergy Clin Immunol. 2025 Apr 26:S0091-6749(25)00461-0. doi: 10.1016/j.jaci.2025.04.021. Online ahead of print. J Allergy Clin Immunol. 2025. PMID: 40294720 No abstract available.
  • Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies.
    Zhu X, Yu Y, Li Y, Wang P, Li Y, McCabe C, Chen S, Langenfeld HE, Hanson AC, Sharp BE, Woltzen A, Crowson CS, Markovic SN, Davis JM 3rd, Dong H, Thanarajasingam U, Zeng H. Zhu X, et al. medRxiv [Preprint]. 2025 Jul 9:2025.06.06.25328991. doi: 10.1101/2025.06.06.25328991. medRxiv. 2025. PMID: 40502578 Free PMC article. Preprint.
  • Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency.
    Castagnoli R, Pala F, Subramanian P, Oguz C, Schwarz B, Lim AI, Burns AS, Fontana E, Bosticardo M, Corsino C, Angelova A, Delmonte OM, Kenney H, Riley D, Smith G, Ott de Bruin L, Oikonomou V, Dos Santos Dias L, Fink D, Bohrnsen E, Kimzey CD, Marseglia GL, Alva-Lozada G, Bergerson JRE, Brett A, Brigatti KW, Dimitrova D, Dutmer CM, Freeman AF, Ale H, Holland SM, Licciardi F, Pasic S, Poskitt LE, Potts DE, Dasso JF, Sharapova SO, Strauss KA, Ward BR, Yilmaz M, Kuhns DB, Lionakis MS, Daley SR, Kong HH, Segre JA, Villa A, Pittaluga S, Walter JE, Vujkovic-Cvijin I, Belkaid Y, Notarangelo LD. Castagnoli R, et al. J Exp Med. 2025 Aug 4;222(8):e20241993. doi: 10.1084/jem.20241993. Epub 2025 May 2. J Exp Med. 2025. PMID: 40314722
  • Factors associated with and kinetics of anti-IFN-α autoantibodies in RAG1/2 deficiency.
    Wang C, Potts DE, Sun B, Toth M, Ujhazi B, Sharapova S, Miller R, Rosen L, Yilmaz M, Larsen K, Delmonte OM, Poskitt LE, Allenspach EJ, de la Morena MT, Ward BR, Hernandez JD, Geier CB, Bolanos HZ, Al-Herz W, Kuijpers TW, Petrov AA, Savic S, Chen K, Westermann-Clark E, Dutmer CM, Kanariou MG, Adeli M, Palma P, Bonfim C, Lycopoulou E, Wolska-Kusnierz B, de Barros Dorna M, Dbaibo G, Bleesing J, Moshous D, Licciardi F, Neven B, Schuetz C, Geha RS, Miano M, Goldman SC, Raasch J, Gonzalez-Granado LI, Celmeli F, Baris S, Abraham RS, Buchbinder DK, Butte MJ, Wang JY, Wang X, Strauss KA, Holland SM, Notarangelo LD, Walter JE. Wang C, et al. J Allergy Clin Immunol Glob. 2025 Jun 23;4(3):100521. doi: 10.1016/j.jacig.2025.100521. eCollection 2025 Aug. J Allergy Clin Immunol Glob. 2025. PMID: 40697949 Free PMC article.

References

    1. Oettinger MA, Schatz DG, Gorka C, Baltimore D, RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517–1523 (1990). - PubMed
    1. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR, RAG mutations in human B cell-negative SCID. Science 274, 97–99 (1996). - PubMed
    1. Notarangelo LD, Kim MS, Walter JE, Lee YN, Human RAG mutations: Biochemistry and clinical implications. Nat. Rev. Immunol 16, 234–246 (2016). - PMC - PubMed
    1. IJspeert H, Driessen GJ, Moorhouse MJ, Hartwig NG, Wolska-Kusnierz B, Kalwak K, Pituch-Noworolska A, Kondratenko I, van Montfrans JM, Mejstrikova E, Lankester AC, Langerak AW, van Gent DC, Stubbs AP, van Dongen JJM, van der Burg M, Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes. J. Allergy Clin. Immunol 133, 1124–1133 (2014). - PMC - PubMed
    1. Schuetz C, Huck K, Gudowius S, Megahed M, Feyen O, Hubner B, Schneider DT, Manfras B, Pannicke U, Willemze R, Knuchel R, Gobel U, Schulz A, Borkhardt A, Friedrich W, Schwarz K, Niehues T, An immunodeficiency disease with RAG mutations and granulomas. N. Engl. J. Med 358, 2030–2038 (2008). - PubMed

Publication types